These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 36175801)
1. Serum-derived extracellular vesicles promote the growth and metastasis of non-small cell lung cancer by delivering the m6A methylation regulator HNRNPC through the regulation of DLGAP5. Shi S; Wu T; Ma Z; Zhang X; Xu K; Tian Q; Gao L; Yin X; Xu S; Yang S J Cancer Res Clin Oncol; 2023 Jul; 149(8):4639-4651. PubMed ID: 36175801 [TBL] [Abstract][Full Text] [Related]
2. HNRNPC, a predictor of prognosis and immunotherapy response based on bioinformatics analysis, is related to proliferation and invasion of NSCLC cells. Gu Z; Yang Y; Ma Q; Wang H; Zhao S; Qi Y; Li Y Respir Res; 2022 Dec; 23(1):362. PubMed ID: 36536402 [TBL] [Abstract][Full Text] [Related]
3. RNA-binding protein KHSRP promotes tumor growth and metastasis in non-small cell lung cancer. Yan M; Sun L; Li J; Yu H; Lin H; Yu T; Zhao F; Zhu M; Liu L; Geng Q; Kong H; Pan H; Yao M J Exp Clin Cancer Res; 2019 Nov; 38(1):478. PubMed ID: 31775888 [TBL] [Abstract][Full Text] [Related]
4. HNRNPC modulates PKM alternative splicing via m6A methylation, upregulating PKM2 expression to promote aerobic glycolysis in papillary thyroid carcinoma and drive malignant progression. Rong S; Dai B; Yang C; Lan Z; Wang L; Xu L; Chen W; Chen J; Wu Z J Transl Med; 2024 Oct; 22(1):914. PubMed ID: 39380010 [TBL] [Abstract][Full Text] [Related]
6. Analysis and validation of m6A regulatory network: a novel circBACH2/has-miR-944/HNRNPC axis in breast cancer progression. Lv W; Tan Y; Xiong M; Zhao C; Wang Y; Wu M; Wu Y; Zhang Q J Transl Med; 2021 Dec; 19(1):527. PubMed ID: 34952600 [TBL] [Abstract][Full Text] [Related]
7. The m6A reader HNRNPC promotes glioma progression by enhancing the stability of IRAK1 mRNA through the MAPK pathway. Chen JJ; Lu TZ; Wang T; Yan WH; Zhong FY; Qu XH; Gong XC; Li JG; Tou FF; Jiang LP; Han XJ Cell Death Dis; 2024 Jun; 15(6):390. PubMed ID: 38830885 [TBL] [Abstract][Full Text] [Related]
8. Bioinformatic analyses and experimental validation of the role of m6A RNA methylation regulators in progression and prognosis of adrenocortical carcinoma. Xu F; Guan Y; Ma Y; Xue L; Zhang P; Yang X; Chong T Aging (Albany NY); 2021 Apr; 13(8):11919-11941. PubMed ID: 33952721 [TBL] [Abstract][Full Text] [Related]
9. HNRNPC promotes estrogen receptor-positive breast cancer cell cycle by stabilizing WDR77 mRNA in an m6A-dependent manner. Xu W; Huang Z; Xiao Y; Li W; Xu M; Zhao Q; Yi P Mol Carcinog; 2024 May; 63(5):859-873. PubMed ID: 38353359 [TBL] [Abstract][Full Text] [Related]
10. Smoking-Induced M2-TAMs, via circEML4 in EVs, Promote the Progression of NSCLC through ALKBH5-Regulated m6A Modification of SOCS2 in NSCLC Cells. Cheng C; Wang P; Yang Y; Du X; Xia H; Liu J; Lu L; Wu H; Liu Q Adv Sci (Weinh); 2023 Aug; 10(22):e2300953. PubMed ID: 37246269 [TBL] [Abstract][Full Text] [Related]
11. HNRNPC mediates lymphatic metastasis of cervical cancer through m6A-dependent alternative splicing of FOXM1. Liu YY; Xia M; Chen ZB; Liao YD; Zhang CY; Yuan L; Pan YW; Huang H; Lu HW; Yao SZ Cell Death Dis; 2024 Oct; 15(10):732. PubMed ID: 39375330 [TBL] [Abstract][Full Text] [Related]
12. N6-methylation of RNA-bound adenosine regulator HNRNPC promotes vascular endothelial dysfunction in type 2 diabetes mellitus by activating the PSEN1-mediated Notch pathway. Cai Y; Chen T; Wang M; Deng L; Li C; Fu S; Xie K Diabetes Res Clin Pract; 2023 Mar; 197():110261. PubMed ID: 36681355 [TBL] [Abstract][Full Text] [Related]
13. M6A regulator expression patterns predict the immune microenvironment and prognosis of non-small cell lung cancer. Liu X; Ma C; Liu H; Sun Z; Luo J J Cancer Res Clin Oncol; 2022 Oct; 148(10):2803-2814. PubMed ID: 35596010 [TBL] [Abstract][Full Text] [Related]
14. The m6A reader HNRNPC predicts adverse prognosis and promotes the progression of colorectal cancer. Yu YM; Hu Y Technol Health Care; 2024; 32(3):1445-1453. PubMed ID: 37661903 [TBL] [Abstract][Full Text] [Related]
15. Reduction of miR-744 delivered by NSCLC cell-derived extracellular vesicles upregulates SUV39H1 to promote NSCLC progression via activation of the Smad9/BMP9 axis. Gao L; Tian Q; Wu T; Shi S; Yin X; Liu L; Zheng L; Wang P; Tian Y; Xu S J Transl Med; 2021 Jan; 19(1):37. PubMed ID: 33472665 [TBL] [Abstract][Full Text] [Related]
16. Four m6A RNA Methylation Gene Signatures and Their Prognostic Values in Lung Adenocarcinoma. Wang Y; Zhao X; Li J; Wang X; Hu W; Zhang X Technol Cancer Res Treat; 2022; 21():15330338221085373. PubMed ID: 35343834 [No Abstract] [Full Text] [Related]
17. Selective sorting and secretion of hY4 RNA fragments into extracellular vesicles mediated by methylated YBX1 to promote lung cancer progression. Li C; Wang W; Sun Y; Ni Y; Qin F; Li X; Wang T; Guo M; Sun G J Exp Clin Cancer Res; 2022 Apr; 41(1):136. PubMed ID: 35410432 [TBL] [Abstract][Full Text] [Related]
18. Extracellular vesicle-derived LINC00482 induces microglial M2 polarization to facilitate brain metastasis of NSCLC. Xu W; Patel N; Deng Y; Ding S; Wang T; Zhang H Cancer Lett; 2023 May; 561():216146. PubMed ID: 36963460 [TBL] [Abstract][Full Text] [Related]
20. HNRNPC downregulation inhibits IL-6/STAT3-mediated HCC metastasis by decreasing HIF1A expression. Liu D; Luo X; Xie M; Zhang T; Chen X; Zhang B; Sun M; Wang Y; Feng Y; Ji X; Li Y; Liu B; Huang W; Xia L Cancer Sci; 2022 Oct; 113(10):3347-3361. PubMed ID: 35848884 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]